- otherd
|
20.4%
|
1reference
|
1reference
|
- Il-1RN*2
|
16.3% (0.73)
|
1.1 (0.80–1.66)
|
1.03 (0.60–1.76)
|
CMV-serostatus
| | | |
- negative
|
20.7%
|
1reference
|
1reference
|
- positive
| |
0.91 (0.55–1.52)
|
1.00 (0.59–1.72)
|
- positive, titre < median
|
16.7%
|
0.74 (0.38–1.43)
|
0.78 (0.40–1.54)
|
- positive titre ≥ median
|
22.1% (0.54)
|
1.12 (0.61–2.05)
|
1.32 (0.69–2.52)
|
IL-1 RA and CMV serostatus
| | | |
- IL-otherd and CMV-negative
|
21.9%
|
1reference
|
1reference
|
- IL-otherd and CMV-positive
|
19.1%
|
0.86 (0.50–1.45)
|
0.94 (0.54–1.64)
|
- Il-1RN*2 and CMV-negative
|
12.5%
|
0.56 (0.13–2.36)
|
0.37 (0.08 – 1.67)
|
- Il-1RN*2 and CMV-positive
|
21.4% (0.83)
|
0.96 (0.32–3.43)
|
0.95 (0.27 – 3.38)
|